Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - HAEMONETICS CORP | b80592e10vk.htm |
| EX-21 - EX-21 - HAEMONETICS CORP | b80592exv21.htm |
| EX-10.S - EX-10S - HAEMONETICS CORP | b80592exv10ws.htm |
| EX-32.1 - EX-32.1 - HAEMONETICS CORP | b80592exv32w1.htm |
| EX-32.2 - EX-32.2 - HAEMONETICS CORP | b80592exv32w2.htm |
| EX-31.1 - EX-31.1 - HAEMONETICS CORP | b80592exv31w1.htm |
| EX-31.2 - EX-31.2 - HAEMONETICS CORP | b80592exv31w2.htm |
| EX-10.U - EX-10U - HAEMONETICS CORP | b80592exv10wu.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the
incorporation by reference in the Registration Statements (Form S-8 Nos.
333-61453, 333-61455, 333-60020, 333-62598, 333-136839 and
333-149205) of our reports dated June 1,
2010, with respect to the consolidated financial statements and schedule of Haemonetics Corporation and subsidiaries and the
effectiveness of internal control over financial reporting of Haemonetics Corporation and subsidiaries, included in
this Annual Report (Form 10-K) for the fiscal year ended April 3, 2010.
/s/ Ernst & Young LLP
Boston, Massachusetts
June 1, 2010
June 1, 2010